comparemela.com

Latest Breaking News On - Relay therapeutics - Page 6 : comparemela.com

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results, Beats Estimates By $0.08 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Stifel-nicolaus
Relay-therapeutics-inc
Relay-therapeutics
Get-free-report
Relay-therapeutics-daily

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results

Relay Therapeutics (NASDAQ:RLAY) Issues Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Stifel-nicolaus
Nasdaq
Relay-therapeutics-inc
Relay-therapeutics-company-profile
Relay-therapeutics
Get-free-report
Relay-therapeutics-daily

Relay Therapeutics (NASDAQ:RLAY) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS

Relay Therapeutics (NASDAQ:RLAY) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Leerink-partnrs
Stifel-nicolaus
Relay-therapeutics-inc
Relay-therapeutics-company-profile
Relay-therapeutics
Get-free-report
Therapeutics-stock-down
Relay-therapeutics-daily

RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips RLAY stock results show that Relay Therapeutics beat analyst estimates for earnings per share…

Market-news
Stock-advice
Relay-therapeutics
Relay-therapeutics-beats
Beats-revenue
News
Ggregator
Reaking-news
Uration
Media

Relay Therapeutics, Inc. (NASDAQ:RLAY) CFO Sells 1,695 Shares

Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) CFO Thomas Catinazzo sold 1,695 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $6.38, for a total transaction of $10,814.10. Following the transaction, the chief financial officer now directly owns 339,803 shares […]

Los-angeles
California
United-states
Thomas-catinazzo
Stifel-nicolaus
Leerink-partnrs
Mesirow-financial-investment-management-inc
Los-angeles-capital-management
Nasdaq
Victory-capital-management-inc
Securities-exchange-commission
Allspring-global-investments-holdings

vimarsana © 2020. All Rights Reserved.